A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Conditions: Renal Cell Carcinoma Metastatic Interventions: Drug: JMKX003948 Sponsors: Jemincare; Zhejiang Hangyu Pharmaceutical Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials